advertisement
Journal of Ocular Pharmacology and Therapeutics 34
Showing records 1 to 25 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics74615 Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications
Di Zazzo A
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 670-677
74106 The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies
Cavet ME
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 52-60
74248 Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization
Trese MGJ
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 591-597
74182 Targets of Neuroprotection in Glaucoma
He S
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 85-106
74165 The Effect of Posture on Intraocular Pressure and Systemic Hemodynamic Parameters in Treated and Untreated Patients with Primary Open-Angle Glaucoma
Katsanos A
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 598-603
74091 Making Basic Science Studies in Glaucoma More Clinically Relevant: The Need for a Consensus
Toris CB
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 501-518
74445 The Antiangiogenesis Effect of Pirfenidone in Wound Healing In Vitro
Liu X
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 693-703
74165 The Effect of Posture on Intraocular Pressure and Systemic Hemodynamic Parameters in Treated and Untreated Patients with Primary Open-Angle Glaucoma
Dastiridou AI
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 598-603
74248 Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization
Lewis AW
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 591-597
74445 The Antiangiogenesis Effect of Pirfenidone in Wound Healing In Vitro
Yang Y
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 693-703
74615 Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications
Roberti G
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 670-677
74182 Targets of Neuroprotection in Glaucoma
Stankowska DL
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 85-106
74091 Making Basic Science Studies in Glaucoma More Clinically Relevant: The Need for a Consensus
Gelfman C
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 501-518
74106 The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies
DeCory HH
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 52-60
74182 Targets of Neuroprotection in Glaucoma
Ellis DZ
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 85-106
74091 Making Basic Science Studies in Glaucoma More Clinically Relevant: The Need for a Consensus
Whitlock A
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 501-518
74445 The Antiangiogenesis Effect of Pirfenidone in Wound Healing In Vitro
Guo X
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 693-703
74615 Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications
Mashaghi A
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 670-677
74248 Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization
Blachley TS
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 591-597
74165 The Effect of Posture on Intraocular Pressure and Systemic Hemodynamic Parameters in Treated and Untreated Patients with Primary Open-Angle Glaucoma
Quaranta L
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 598-603
74445 The Antiangiogenesis Effect of Pirfenidone in Wound Healing In Vitro
Liu L
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 693-703
74248 Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization
Stein JD
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 591-597
74165 The Effect of Posture on Intraocular Pressure and Systemic Hemodynamic Parameters in Treated and Untreated Patients with Primary Open-Angle Glaucoma
Rulli E
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 598-603
74615 Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications
Abud TB
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 670-677
74091 Making Basic Science Studies in Glaucoma More Clinically Relevant: The Need for a Consensus
Sponsel WE
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 501-518
